Introduction
Studies of protein synthesis regulation led to the discovery that overexpression of the translation initiation factor eIF4E can transform cells in tissue culture (Lazaris-Karatzas et al., 1990; De Benedetti et al., 1990 . Elevated levels of eIF4E result in the selective increase of a few proteins whose mRNAs arè translationally repressed' but that most directly aect malignancy (Kevil et al., 1995 (Kevil et al., , 1996 Shantz and Pegg, 1994) . For instance, a large increase in FGF-2 and VPF expression could be demonstrated in cells transformed by eIF4E. These two potent cytokines can drastically increase vascularization in vivo, which is essential for tumor growth (Folkman et al., 1976) . Furthermore, eIF4E was established as a bona ®de tumor marker, as it is uniformly elevated in human breast carcinomas but not in benign ®broadenomas (Kerekatte et al., 1995) .
The cure rate for HNSCC is poor, primarily because of a high rate of recurrence at the primary site (60 ± 70%) (Gilbert and Kagan, 1974) . This is largely due to inadequate surgical excision, which results in a poor outcome (Looser et al., 1978) . The ability to detect malignancy at the molecular level with appropriate tumor markers could help prevent the high local recurrence rate by allowing for a more precise determination of cancer involvement at the surgical margins. This would also help in predicting recurrence and possibly lead to adjunctive therapies for patients at higher risk for recurrence. We describe our ®ndings that eIF4E is elevated in all HNSCC so far analysed. Furthermore, our results suggest that its presence in histologically normal resection margins correlate with local recurrence. The potential use of eIF4E as a prognostic marker and its role in de®ning surgical margins are discussed.
Results

Analysis of eIF4E in tumor samples by Western blot
This analysis revealed a 3 ± 22-fold elevation of eIF4E in all the 26 primary HNSCC samples compared to normal controls. All negative controls showed low levels of eIF4E. Figure 1a is a histogram of the eIF4E elevation obtained in biopsies from 26 patients with HNSCC compared to the average value obtained from four control non-cancer biopsies.
eIF4E expression in histologically negative surgical margins
Of 23 patients that underwent surgical resection of the primary tumor, 11 patients did not have elevated eIF4E in the surgical margins. Figure 2a is a representative blot showing alternating lanes of tumor and histologically normal mucosa obtained from the surgical resection margins. As can be seen, all tumor samples overexpress eIF4E, whereas the adjacent mucosa does not have elevated levels of eIF4E, except in patient 12: and this patient has already recurred.
Twelve of the 23 patients that had surgical margins analysed for eIF4E had a 3 ± 10-fold elevation of eIF4E in at least one of the surgical margins. These margins were all de®ned as histologically negative for tumor on ®nal pathology. Figure 2b shows representative results of patients that had elevated levels of eIF4E in the surgical margins. Patient 8 has one margin (lane SM8a) that has baseline levels of eIF4E and two margins SM8b and SM8c that had elevated levels of eIF4E.
SM8b had levels of eIF4E equivalent to that in the tumor T8. Also shown is patient 11, with two surgical margins (SM11a, b) positive for eIF4E, and two (SM11c, d) with baseline level, and this patient has also recurred. Patient 4 had SM4, inferior tracheal margin overexpress eIF4E, to a level equivalent to that in his tumor and this patient died of a local recurrence.
In situ immunohistochemistry on the paran blocks of patient 4 was performed. The tumor and inferior tracheal margin of patient 4 was reanalysed as the patient succumbed to a local tracheal recurrence 1 month after surgery. A Zenker's diverticulum was used as a negative control. Immunohistochemical staining of the same inferior tracheal margin sent for histology, showed areas of atypical cells stained positive for eIF4E. Figure 3e and g are H&E stains of the inferior tracheal margin of the patient described above. Figure 3f and h shows corresponding sections stained with eIF4E antibody, using the peroxidase DAB/Cobalt color development. The cells overexpressing eIF4E are stained blue/purple. Figure 3c represents an H&E stain of the larynx tumor of this patient and Figure 3d is the corresponding eIF4E stain. For comparison, Figure 3a represents an H&E stain of a Zenker's hypopharyngeal diverticulum (normal tissue) and shows the corresponding immunohistochemical eIF4E stain (Figure 3b ).
Treatment outcome
Patients received standard post-operative radiation therapy based on the ®nal histopathologic ®ndings of their resected specimens. Five of the 12 patients with elevated levels of eIF4E in the surgical margins have recurred rapidly, while none of the 11 patients with baseline levels of eIF4E in the surgical margins have recurred. Two of the ®ve patients recurred prior to starting radiation therapy. However one can see from Table 1 that eight patients in the eIF4E positive margin group received radiation while ony ®ve patients in the eIF4E negative margin group received radiation. Patient 4 and 12 have succumbed to their disease and patients 11, 16 and 19 are still alive with disease. These patients all have biopsy proven recurrence. KaplanMeier survival curves for eIF4E positive and negative margins are presented in Figure 1b . The survival curves were signi®cantly dierent by Log-rank test (P=0.02). The average length of follow-up was 7.8 months in the 12 patients with positive margins, which is signi®cantly less than the average follow-up period of 13.6 months for the 11 patients with negative margins (unpaired ttest, P50.05). Table 1 summarizes the characteristics of patients with and without elevated levels of eIF4E in the surgical margins that were histologically negative for tumor. If more than one margin had increased levels of eIF4E, the surgical margin with the highest level of eIF4E was selected for representation in the table.
In this pilot study of 26 patients, the average levels of eIF4E in the tumor was not signi®cantly dierent over sex or race (unpaired t-test, P40.05). There was no correlation with age, clinical stage, pathological stage, histological grade or lymph node metastasis (Spearman's correlation, P40.05). The average eIF4E overexpression in tumor samples was also not dierent over the sites (One-way analysis of variance with larynx, hypopharynx, tonsil and other sites grouped together). However, the average level of eIF4E in the tumor of patients with positive margins was higher (8.45) compared to patients with negative margins (4.47). This was statistically signi®cant (unpaired t-test, P=0.03). (e and f) . The primary antiserum was used at a dilution of 1 : 500 for 1/2 h. Addition of the secondary antiserum and color development using the peroxidase DAB/Cobalt color development assay (Harlow E, 1988 ) was then performed
Discussion
Our study of eIF4E oncoprotein demonstrates consistently elevated expression in HNSCC in contrast to benign lesions including hyperproliferative and inflammatory processes, which show normal levels of expression. Thus eIF4E appears to be a sensitive and speci®c marker for head and neck malignancies as opposed to benign lesions, consistent with similar ®ndings in breast carcinomas (Kerekatte et al., 1995) . eIF4E is overexpressed in breast carcinomas (primarily adenocarcinomas) and also in HNSCC. These are histopathologically dierent malignancies with dierent etiologies. We believe that somewhere in the multi-step pathway of carcinogenesis, elevation of eIF4E is a necessary event in the progression of most solid tumors. A simple explanation is that malignant tissue consists of dividing cell which require greater protein synthesis to achieve adequate proliferation rates, greater than their rate of apoptosis. However, overexpression of eIF4E does not closely re¯ect the proliferative status of cells but rather their malignant properties, as indicated in a study with breast cell lines (Anthony et al., 1996) 
. eIF4E promotes this by speci®cally increasing the translational eciency of several oncogene transcripts, leading to overexpression of their products. We postulate that with higher levels of eIF4E, weak mRNAs with a long and highly structured 5'-untranslated-region are translated better. FGF-2 and VPF (Kevil et al., 1995 (Kevil et al., , 1996 are two such weak mRNAs that are translationally upregulated by eIF4E and may greatly increase vascularization of the tumor.
Most studies thus far have focused on the activity rather than the expression of eIF4E. While the activity of eIF4E is modulated by phosphorylation, which changes either in response to mitogenic activation or during the cell cycle (Rhoads, 1993; Sonenberg, 1993) , its level of expression is also important for the regulation of cell growth. We used a polyclonal antibody to recombinant human eIF4E in this study. It appears to recognize the phosphorylated form(s) of eIF4E equally well, and we frequently detect closelyspaced immunoreactive bands on Western blots. Unfortunately, their resolution was not very consistent from one blot to another. Such analysis would have required the use of isoelectric focusing gels (instead of SDS ± PAGE), but the solubility of specimens in IEF sample buer has been a problem. Thus, it remains to be seen whether the excess of eIF4E in dierent tumor samples is fully active (i.e. phosphorylated). It is also important to determine if the expression of the inhibitory proteins 4E-BPs is altered in carcinomas, since it is the ratio of eIF4E to 4E-BPs that should most directly aect translation initiation rates. This was dramatically demonstrated by the overexpression of 4E-BPs in cells transformed by v-src causing a signi®cant reversion of the transformed phenotype (Rousseau et al., 1996) .
The elevation of eIF4E in all 26 HNSCC makes it a very good tumor marker for head and neck cancers. Abnormal expression of oncogenes has been implicated in the development of head and neck cancer and can potentially mark areas of tumor cells. To date studies with most oncogenes demonstrate a lack of the necessary sensitivity and/or speci®city needed for a reliable marker (Maestro et al., 1992; Beckhardt et al., 1995; Kiaris et al., 1995) . Studies of p53 reported that some of the negative histopathologic margins contained a small but distinct number of cancer cells (Brennan et al., 1995) . However, as indicated in the study, p53 mutations (when identi®able) occur in only 30% of the tumors. Furthermore, assays based on PCR and sequencing are technically challenging, prone to artifacts and require a minimum of 3 days to complete. The complexity of PCR-ampli®cation of mutated alleles in cancer cells next to a large background of normal cells (in surgical margins) makes it dicult to use on a routine basis. The eIF4E elevation in individual cancer cells is frequently 15 ± 30-fold (Kerekatte et al., 1995) . Thus, even a 10% tumor representation at the margins would give a positive signal for eIF4E elevation by Western blot. Additionally immunohistologic staining can be implemented at the time of surgery. We have recently optimized the assays for immunohistochemical staining 13.59 *4E/T represents the fold elevation in levels of eIF4E in the tumor compared to the non-cancer patients. **4E/SM represents the fold elevation of eIF4E in the histologically negative surgical margin with the highest elevation of 4E, compared to levels of eIF4E in the noncancer patients of eIF4E in surgical margins as seen in Figure 3 . However prospective studies need to be performed on margins using immunohistochemical staining to use this technique as an adjunct to histopathologic clearance of surgical margins. The long duration of head and neck surgery makes it feasible to implement on-site determination of surgical margins based on eIF4E levels.
It is important to note we found no recurrence in patients with normal levels of eIF4E in the surgical margins while 42% of patients with elevated levels of eIF4E in the surgical margins have recurred at an average of 3.4 months of their surgery. Twelve of the 23 surgical margins showed elevated levels of eIF4E, despite being considered histologically normal by standard hematoxylin and eosin (H&E) staining techniques. Five of these 12 patients had a rapid local recurrence. This is consistent with persistent disease. Longer follow-up will determine if eIF4E can predict local recurrence in most of these patients.
The adequacy of surgical resection of the primary tumor is conventially determined intra-operatively by histopathologic (H&E) diagnosis based on frozen section results that are obtained from the surgical margins during the procedure (Gandour-Edwards et al., 1993). The samples which are analysed are taken at points approximately 1 ± 2 cms away from the gross tumor. If microscopic tumor is present at the surgical margin, the rate of local recurrence increases substantially and the survival rate decreases. Local recurrence occurs in up to 50% of the patients even with microscopically negative surgical margins and is the leading cause of treatment failure (Jesse and Sugarbaker, 1976; Davidson et al., 1981) . The process of malignant transformation begins at the molecular level, prior to any phenotypic abnormality that is seen histologically. Thus, being able to detect malignant changes at the molecular level during surgery may provide a much more sensitive and earlier detection method than histopathologic diagnosis. In addition, occult malignant cells may go unrecognized because of sampling error or interpretative uncertainties by the pathologist. If Western blot results show elevated eIF4E in surgical margins that are histologically free of tumor then postoperative radiotherapy and/or chemotherapy would certainly be considered to improve the treatment outcome. More important intraoperative immunohistochemistry with eIF4E antiserum of surgical margins can be performed (preferably by direct immunodetection) and if the histologically normal margins are found positive for eIF4E further resection at the time of surgery could improve the overall success.
In this study there appeared to be no correlation between general clinical and pathologic parameters and the level of eIF4E. This is similar to reports on clinicopathologic correlations with other oncogenes in head and neck cancer (Beckhardt et al., 1989; Field et al., 1989) . The patients in the eIF4E negative margin group did have eIF4E mean tumor levels that were half that in the positive margin group (Table 1) . This may make eIF4E levels in the primary tumor an independent prognostic factor. It could be argued that since the eIF4E negative margin group had levels of eIF4E that were half that of the positive group, it would be less likely to pick up a positive signal in the group of patients with lower eIF4E levels. However, our Western blot assay is sensitive enough to pick up even a twofold elevation, hence having low levels of eIF4E in the tumors would not preclude detection of eIF4E-positive margins.
The success of HNSCC treatment is largely dependent on accurate staging. The TNM classification is associated with a well-recognized diculty in predicting individual outcome. Not infrequently, tumors that are similarly staged on the basis of their origin, size and metastatic node involvement, will dier dramatically in their clinical course and response to therapy. It may be that biologic factors contribute to the aggressive behavior of dierent tumors. Identification of such cellular determinants would constitute a major advance in the prediction and management of human neoplasms. Recently, attention has been focused on cellular oncogenes as potential prognostic predictors of HNSCC aggressiveness (Field et al., 1989) . Our study has shown that eIF4E may play such a role in this area. The absence of overexpression of eIF4E in mucosa from patients with chronic tonsillitis, nasal polyps, history of radiation treatment, and in many surgical resection margins makes eIF4E a speci®c tumor marker. Its overexpression in all the head and neck cancers analysed to date underscores its sensitivity. Although the role of eIF4E in oncogenesis is not fully elucidated, it holds great promise as a guide for therapeutic decisions in the clinical arena.
Materials and methods
Samples and controls
Twenty-six consecutive newly diagnosed HNSCC patients at Louisiana State University Medical Center and the Veterans Administration Hospital in Shreveport were studied. Approvals were obtained by the Institutional Review Board, and portions of the neoplasm were collected with consent of the patient. All 26 patients had a single primary tumor, and none had undergone preoperative treatment. Twenty-three patients underwent surgical resection as the primary treatment modality; the remaining three patients underwent radiation and/or chemotherapy. Tumor samples from 23 patients were obtained in the operating room at the time of surgical resection. These samples included tumor and adjacent nonmalignant mucosa from the surgical margins. The remaining three patients had local biopsies of the tumor at the time of the initial diagnosis and staging procedure.
Seven controls were obtained from non-cancer patients encompassing dierent benign conditions from various sites of the head and neck. These included mucosa from the anterior tonsil pillar of two non-smokers with chronic tonsillitis and hypertrophic tonsils. Also a nasal polyp and hypopharyngeal diverticulum with chronic in¯ammation from smokers were obtained.
Histopathologic assessment
The resected tumor and the surgical margins that were sent for frozen section were processed in a standard fashion. All slides were read by the sta pathologist prior to the analysis with eIF4E antiserum and the results were kept blind, until the time of direct comparison. Later, histologically negative surgical margins that had elevated levels of eIF4E were reviewed again by our pathologist to con®rm absence of histological evidence of clear-cut malignancy.
Preparation of tissue lysates and determination of protein concentration
Samples obtained in the operating room immediately following resection of the primary lesion were dissected, frozen in liquid nitrogen and then stored in a 7908C freezer. The samples (&5 mg) were suspended in 0.5 ml RIPA buer and mechanically macerated with a polytron (15 000 r.p.m. for 1 min). The macerates were centrifuged at 30 000 g for 10 min at 48C to remove cell debris and the extracts were promptly frozen. Protein concentrations were determined using the BCA protein assay kit (Pierce, Rockford, IL), against a standard graph of known BSA protein dilution.
Western blot (immunoblot) analyses of tissues
The rabbit anti-eIF4E antiserum was prepared in our laboratory (Kerekatte et al., 1995) and HRP-conjugated secondary antiserum was purchased from Sigma (St Louis, MO). Equal amounts of tissue extract (30 mg protein) were analysed on 12% PAGE/SDS. The proteins were electroblotted onto a membrane (Immobilon, Millipore, Bedford, MA), and probed as previously described (Kerekatte et al., 1995) . After development with the chromogen DAB, the Western blots were scanned and analysed with a Molecular Dynamics Personal Densitometer and IQ software (Sunnyvale, CA). The degree of elevation was determined by comparing the ratio of the sample band intensity to the negative control(s) on each blot. The densitometric values from patients with SCC were divided by the reading obtained from the negative controls, and a relative score was given. The scores were recorded in a spreadsheet along with demographic, clinical and histologic data. The analysis of all the samples was performed three times, using dierent amounts of tissue extract, with reproducible results.
Statistical analysis
The data on patient characteristics and surgical margins was analysed statistically with P.C. SAS Version 6.11. The probability of a local recurrence of cancer was analysed using the log rank test and a Kaplan-Meier curve was generated.
